Marine biotoxins research
Ended Awarded Last action
- Contract number
- 75F40124F19027
- Awardee
-
Goldbelt C6, LLC UEI LSY9B62DKAC8
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $139,814
Award facts
- Opportunity
-
- 75F40123R00078 Solicitation number
- Contract value 100% obligated
- $139,814.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Not Available for Competition Only One Source
- Pricing
- Labor Hours
- Place of performance
- Silver Spring, MD 20903, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Close Out | -$6,808 | |
| Other Administrative Action | $0 | |
| Original award | $146,622 |
About this award
The Food and Drug Administration (FDA) issued a delivery order valued at $139,814.16 to Goldbelt C6, LLC for marine biotoxins research, with an ultimate completion date of August 29, 2025. This labor-hour priced delivery order, awarded on July 18, 2024, will be performed in Silver Spring, Maryland, and represents an administrative action and closeout modification to an existing vehicle. The award was made without a set-aside designation, though Goldbelt C6 is an 8(a) certified small disadvantaged business and Alaska Native Corporation subsidiary. This delivery order is issued under Goldbelt C6's existing $20 million single-award indefinite delivery contract with the FDA for research and development support services through August 2028, which covers toxicology research, data analysis, scientific support, and regulatory science expertise.
Goldbelt C6's expertise in marine biotoxins research aligns with the FDA's regulatory mission to protect public health through food safety assessments and scientific analysis. The contractor brings extensive experience across federal agencies, including the Centers for Disease Control and Prevention, Department of State, U.S. Coast Guard, and Defense Health Agency, having demonstrated capability in complex research support, scientific services, and regulatory affairs. The marine biotoxins research initiative supports the FDA's efforts to identify and assess naturally occurring toxins in marine environments, which is critical to ensuring the safety of seafood products and protecting consumers from potential health risks associated with harmful algal blooms and other biotoxin sources.
Quick answers
Who was awarded contract 75F40124F19027?
75F40124F19027 was awarded to Goldbelt C6, LLC by Food and Drug Administration (Department of Health and Human Services) on July 18, 2024.
How much is contract 75F40124F19027 worth?
The government has obligated $139,814 on 75F40124F19027.
Is contract 75F40124F19027 an order under another contract?
Yes. 75F40124F19027 is a delivery order under 75F40123D00017, an indefinite delivery contract.
Was contract 75F40124F19027 competed?
The extent of competition for 75F40124F19027 was not available for competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award